Rosh Dias

Rosh Dias currently serves as Member at The Royal College of Physicians and as Chief Medical Officer at Coherus Oncology, Inc. Former roles include Chief Medical Officer at Indivior PLC (2019–2020), Vice President-Global Scientific Affairs at Amgen, Inc. (2015–2018), VP, Head-Global Medical & Scientific Affairs at Onyx Pharmaceuticals, Inc. (2014–2015), Vice President-Oncology Scientific Operations at Novartis International AG (2004–2014), Head-Clinical Development & Medical Affairs at Novartis Australia Pty Ltd. (2004–2014), Global Medical Director-Oncology at Aventis Pharmaceuticals, Inc., and Chief Medical Officer at Spruce Biosciences, Inc. Education includes a graduate degree from The Royal College of Physicians and a doctorate from Charing Cross Hospital Medical School.